A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2

FEBS Letters

Volumn 470, Issue 2, 2000, Pages 131-134

  Inal, Jameel M ^a   Sim, Robert B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

C2; Complement; Receptor; Schistosoma

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C2; FUNGAL PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; COMPLEMENT ACTIVATION; GLYCOSYLATION; HEMOLYSIS; IMMUNOBLOTTING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SCHISTOSOMA; SHEEP ERYTHROCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, HELMINTH; ANTIGENS, PROTOZOAN; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; COMPLEMENT C2; COMPLEMENT C2A; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C4B; COMPLEMENT PATHWAY, CLASSICAL; ERYTHROCYTES; HELMINTH PROTEINS; HEMOLYSIS; HUMANS; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SCHISTOSOMA; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SHEEP;

OVIS ARIES; SCHISTOSOMA;

EID: 0034708410     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01304-1     Document Type: Article

References (31)

1. Hourcade D., Holers V.M., Atkinson J.P. Adv. Immunol. 45:1989;381-416.
2. Seya T., Nakamura K., Masaki T., Ichihara-Itoh C., Matsumoto M., Nagasawa S. Mol. Immunol. 32:1995;355-360.
3. Gigli I., Fujita T., Nussenzweig V. Proc. Natl. Acad. Sci. USA. 76:1979;6596-6600.
4. Fujita T., Gigli I., Nussenzweig V. J. Exp. Med. 148:1978;1044-1051.
5. Morgan B.P., Meri S. Springer Semin. Immunopathol. 15:1994;369-396.
6. Nicholson-Weller A., Burge J., Fearon D.T., Weller P.F., Austen K.F. J. Immunol. 129:1982;184-189.
7. Fearon D.T. Proc. Natl. Acad. Sci. USA. 76:1979;5867-5871.
8. Kinoshita T., Medof M., Nussenzweig V. J. Immunol. 136:1986;3390-3395.
9. Fujita T., Inoue K., Ogawa K., Iida K., Tamura N. J. Exp. Med. 167:1987;1221-1228.
10. Fearon D.T. Proc. Natl. Acad. Sci. USA. 76:1979;5867-5871.
11. Iida K., Nussenzweig V. J. Exp. Med. 153:1981;1138-1150.
12. Medof M.E., Nussenzweig V. J. Exp. Med. 159:1984;1669-1685.
13. Seya T., Atkinson J.P. Biochemistry. 264:1989;581-588.
14. Seya T., Turner J.R., Atkinson J.P. J. Exp. Med. 163:1986;837-855.
15. Cheung N.-K.V., Walter E.I., Smith-Mensah W.H., Ratnoff W.D., Tykocinski M.C., Medof M.E. J. Clin. Invest. 81:1988;1122-1128.
16. Seya T., Hara T., Matsumoto M., Akedo H. J. Immunol. 145:1990;238-245.
17. Kumar S., Vinci J.M., Pytel B.A., Baglioni C. Cancer Res. 53:1993;348-353.
18. Fatima M., Horta M., Ramalho-Pinto E.J. J. Exp. Med. 174:1991;1399-1406.
19. Joiner K.A., da Silva W.D., Rimoldi M.T., Hamner C.H., Sher A., Kipnis T.L. J. Biol. Chem. 263:1988;11327-11335.
20. Norris K.A., Bradt B., Cooper N.R., So M. J. Immunol. 147:1991;2240-2247.
21. Inal J. Biochim. Biophys. Acta. 1445:1999;283-298.
22. Stenbaek E.I., Koch C., Barkholt V., Welinder K. Mol. Immunol. 23:1986;879-886.
23. Dodds, A.W. and Sim, R.B. (1997) in: Complement, A Practical Approach (Rickwood, D. and Hames, B.D., Eds.), Oxford University Press, Oxford.
24. Rost B., Fariselli P., Casadio R. Protein Sci. 7:1996;1704-1718.
25. Smith M.A., Kerr M.A. Immunology. 56:1985;561-570.
26. Kerr M.A., Gagnon J. Biochem. J. 205:1982;59-67.
27. Bentley D.R. Biochem. J. 239:1986;339-345.
28. Oglesby T.J., Accavitti M.A., Volanakis J.E. J. Immunol. 141:1988;926-931.
29. Xu Y., Volanakis J.E. J. Immunol. 158:1997;5958-5965.
30. Horiuchi T., Macon K.J., Engler J.A., Volanakis J.E. J. Immunol. 147:1991;584-589.
31. Lee J.-O., Rieu P., Arnaout M.A., Liddington R. Cell. 80:1995;631-638.